FSH secretion predominates in vivo and in vitro in patients with non-functioning pituitay adenomas

European Journal of Endocrinology

Volumn 152, Issue 3, 2005, Pages 363-370

  Hanson, P L ^a   Aylwin, S J B ^a   Monson, J P ^a   Burrin, J M ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE;

ADOLESCENT; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION FUNCTION; CULTURE MEDIUM; DATA ANALYSIS; FEMALE; FOLLITROPIN RELEASE; GONADOTROPIN BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS ADENOMA; HYPOPHYSIS CELL; HYPOPHYSIS TUMOR; IN VITRO STUDY; IN VIVO STUDY; LUTEINIZING HORMONE RELEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TUMOR CELL CULTURE;

ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; MALE; MIDDLE AGED; PITUITARY GLAND; PITUITARY NEOPLASMS;

EID: 15944365821     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01854     Document Type: Article

References (23)

1. Surmont DWA, Winslow CLJ, Loizou M, White MC, Adams EF & Mashiter K. Gonadotrophin and alpha subunit secretion by human functionless pituitary adenomas in cell culture: long term effects of LHRH and TRH. Clinical Endocrinology 1983 19 325-336.
2. Snyder PJ. Gonadotroph cell adenomas of the pituitary. Endocrine Reviews 1985 6 552-563.
3. Asa SL, Gerrie BM, Singer W, Horvath E, Kovacs K & Smyth HS. Gonadotrophin secretion in vitro by human pituitary null cell adenomas and oncocytomas. Journal of Clinical Endocrinology and Metabolism 1986 62 1011-1019.
4. Jameson JL, Klibanski A, Black PM, Zervas NT, Lindell CM, Hsu DW, Ridgway EC & Habener JF. Glycoprotein hormone genes are expressed in clinically nonfunctioning pituitary adenomas. Journal of Clinical Investigation 1987 80 1472-1478.
5. Aylwin SJB, Welch JP, Davey CL, Geddes JF, Wood DF, Besser GM, Grossman AB, Monson JP & Burrin JM. The relationship between SF-1 and DAX-1 expression and in vitro gonadotropin secretion in human pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 2001 86 2476-2483.
6. Chaidarun SS & Klibanski A. Gonadotropinomas. Seminars in Reproductive Medicine 2002 20 339-348.
7. Katznelson L, Alexander JM, Bikkal HA, Jameson JL, Hsu DW & Klibanski A. imbalanced follicle stimulating hormone beta subunit hormone biosynthesis in human pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 1992 74 1343-1351.
8. Vaninetti S, Baccarelli A, Romoli R, Fanelli M, Faglia G & Spada A. Effect of aging on serum gonadotrophin levels in healthy subjects and patients with nonfunctioning pituitary adenomas. European Journal of Endocrinology 2000 142 144-149.
9. Katznelson L, Alexander JM & Klibanski A. Clinically nonfunctioning pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 1993 76 1089-1094.
10. Kwekkeboom DJ, de Jong FH & Lamberts SW. Gonadotrophin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotrophin releasing hormone, gonadotrophin releasing hormone and bromocriptine. Journal of Clinical Endocrinology and Metabolism 1989 68 1128-1135.
11. White MC, Daniels M, Newland F, Thompson CJ, Cook D, Dewar J, Perry R, Jewitt R, Mathias D & Murdoch AP. LH and FSH secretion and responses to GnRH and TRH in patients with clinically functionless pituitary adenomas. Clinical Endocrinology 1990 36 681-688.
12. Padmanabhan V & McNeilly AS. Is there an FSH releasing factor? Reproduction 2001 121 21-30.
13. Daneshdoost L, Genarelli TA, Bashey HM, Savino PJ, Sergott RC, Bosley TM & Snyder PJ. Identification of gonadotroph adenomas in men with clinically nonfunctioning adenomas by the LH beta subunit response to thyrotrophin releasing hormone. Journal of Clinical Endocrinology and Metabolism 1993 77 1352 1355.
14. Kourides IA, Weintraub BD, Rosen SW, Ridgway EC, Kliman B & Maloof F. Secretion of alpha subunit of glycoprotein hormones by pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 1976 43 97 106.
15. Ridgway EC. Glycoprotein hormone production by pituitary tumours. In Secretory Tumours of the Pituitary Gland, pp 343 363. Ed. P McL Black. New York: Raven Press, 1984.
16. Mukai K. Pituitary adenomas. Immunocytochemical study of 150 tumours with clinicopathologic correlation. Cancer 1983 52 648 653.
17. Takeda M, Otsuko F, Suzuki J, Kishida M, Ogura T, Tamiya T & Makino H. Involvement of activin/BMP system in development of human pituitary gonadotrophinomas and nonfunctioning adenomas. Biochemical and Biophysical Research Communications 2003 306 812 818.
18. Wessels HT, Hofland LJ, van der Wal R, van Gastel L, van Koetsveld PM, de Herder HH & de Jong FH. In vitro secretion of FSH by cultured clinically nonfunctioning and goriadotroph pituitary adenomas is directly correlated with locally produced levels of activin A. Clinical Endocrinology 2001 54 485 492.
19. Shupnik MA, Pitt LK, Soh AY, Anderson A, Lopes MB & Laws ER Jr. Selective expression of estrogen receptor α and β isoforms in human pituitary tumours. Journal of Clinical Endocrinology and Metabolism 1998 83 3965 3972.
20. Lania A, Gangi E, Romoli R, Losa M, Travaglini P, Meringola D, Ambrosi B, Faglia G, Beck-Peccoz P & Spada A. Impaired oestrogen-induced negative feedback on gonadotrophin secretion in patients with gonadotrophin-secreting and nonfunctioning pituitary adenomas. European Journal of Clinical Investigation 2002 32 335 340.
21. Blumenfeld Z & Ritter M. Inhibin, activin and follistatin in human fetal pituitary and gonadal physiology. Annals of the New York Academy of Sciences 2001 943 34 48.
22. Danila DC, Inder WJ, Zhang X, Alexander JM, Swearingen B, Hedley-Whyte ET & Klibanski A. Activin: effects on neoplastic proliferation of human pituitary tumours. Journal of Clinical Endocrinology and Metabolism 2000 85 1009 1015.
23. Zhou Y, Sun H, Danila DC, Johnson SR, Sigai DP, Zhang X & Klibanski A. Truncated activin type 1 receptor Alk4 isoforms are dominant negative receptors inhibiting activin signalling. Molecular Endocrinology 2000 14 2066 2075.